Direct and long-term detection of gene doping in conventional blood samples

Gene Therapy

Volumn 18, Issue 3, 2011, Pages 225-231

  Beiter, T ^a   Zimmermann, M ^a   Fragasso, A ^a   Hudemann, J ^a   Niess, A M ^a   Bitzer, M ^a   Lauer, U M ^a   Simon, P ^b  

^a UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

^b JOHANNES GUTENBERG UNIVERSITY   (Germany)

Author keywords

doping; doping detection; gene doping; gene transfer; sport

Indexed keywords

GENOMIC DNA; PARVOVIRUS VECTOR;

ADENO ASSOCIATED VIRUS; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ATHLETE; BLOOD; BLOOD SAMPLING; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; DNA SEQUENCE; DOPING; GENE; GENE AMPLIFICATION; GENETIC SCREENING; HUMAN; MALE; MOUSE; NONHUMAN; NORMAL HUMAN; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RELIABILITY; REPRODUCIBILITY; SENSITIVITY AND SPECIFICITY; VIRAL GENE DELIVERY SYSTEM;

ANIMALS; ATHLETIC PERFORMANCE; DEPENDOVIRUS; DOPING IN SPORTS; GENE COMPONENTS; GENE THERAPY; HUMANS; MICE; NUCLEIC ACID AMPLIFICATION TECHNIQUES; POLYMERASE CHAIN REACTION; TRANSGENES; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

ADENO-ASSOCIATED VIRUS;

EID: 79952484973     PISSN: 09697128     EISSN: 14765462     Source Type: Journal    
DOI: 10.1038/gt.2010.122     Document Type: Article

References (24)

1. Wells DJ. Gene doping: the hype and the reality. Br J Pharmacol 2008; 154: 623-631. (Pubitemid 351744949)
2. Mansour MM, Azzazy HM. The hunt for gene dopers. Drug Test Anal 2009; 1: 311-322.
3. Baoutina A, Alexander IE, Rasko JE, Emslie KR. Potential use of gene transfer in athletic performance enhancement. Mol Ther 2007; 15: 1751-1766. (Pubitemid 47434181)
4. World Anti-Doping Agency. A brief history of anti-doping. http://www.wada-ama.org/en/ About-WADA/History/A-Brief-History-of-Anti-Doping, (accessed August 2010).
5. Friedmann T, Rabin O, Frankel MS. Ethics. Gene doping and sport. Science 2010; 327: 647-648.
6. Beiter T, Zimmermann M, Fragasso A, Armeanu S, Lauer UM, Bitzer M et al. Establishing a novel single-copy primer-internal intron-spanning PCR (spiPCR) procedure for the direct detection of gene doping. Exerc Immunol Rev 2008; 14: 73-85.
7. World Anti-Doping Agency. The 2010 prohibited list: international standard. http:// www.wada-ama.org/rtecontent/document/2010-Prohibited-List- FINAL-EN-Web.pdf, (accessed May 2010).
8. Haisma HJ, de Hon O. Gene doping. Int J Sports Med 2006; 27: 257-266.
9. Lee S, Barton ER, Sweeney HL, Farrar RP. Viral expression of insulin-like growth factor-I enhances muscle hypertrophy in resistance-trained rats. J Appl Physiol 2004; 96: 1097-1104. (Pubitemid 38248688)
10. Haidet AM, Rizo L, Handy C, Umapathi P, Eagle A, Shilling C et al. Long-term enhancement of skeletal muscle mass and strength by single gene administration of myostatin inhibitors. Proc Natl Acad Sci USA 2008; 105: 4318-4322. (Pubitemid 351754378)
11. Voutetakis A, Bossis I, Kok MR, Zhang W, Wang J, Cotrim AP et al. Salivary glands as a potential gene transfer target for gene therapeutics of some monogenetic endocrine disorders. J Endocrinol 2005; 185: 363-372. (Pubitemid 40883381)
12. Sagazio A, Xiao X, Wang Z, Martari M, Salvatori R. A single injection of double-stranded adeno-associated viral vector expressing GH normalizes growth in GH-deficient mice. J Endocrinol 2008; 196: 79-88. (Pubitemid 351234573)
13. Arsic N, Zacchigna S, Zentilin L, Ramirez-Correa G, Pattarini L, Salvi A et al. Vascular endothelial growth factor stimulates skeletal muscle regeneration in vivo. Mol Ther 2004; 10: 844-854. (Pubitemid 39419911)
14. Tafuro S, Ayuso E, Zacchigna S, Zentilin L, Moimas S, Dore F et al. Inducible adeno-associated virus vectors promote functional angiogenesis in adult organisms via regulated vascular endothelial growth factor expression. Cardiovasc Res 2009; 83: 663-671.
15. Hojman P, Gissel H, Gehl J. Sensitive and precise regulation of haemoglobin after gene transfer of erythropoietin to muscle tissue using electroporation. Gene Ther 2007; 14: 950-959. (Pubitemid 46865506)
16. Coura Rdos S, Nardi NB. The state of the art of adeno-associated virus-based vectors in gene therapy. Virol J 2007; 4: 99.
17. Baoutina A, Alexander IE, Rasko JE, Emslie KR. Developing strategies for detection of gene doping. J Gene Med 2008; 10: 3-20.
18. Gonin P, Gaillard C. Gene transfer vector biodistribution: pivotal safety studies in clinical gene therapy development. Gene Ther 2004; 11: S98-S108. (Pubitemid 39359454)
19. Mori S, Takeuchi T, Enomoto Y, Kondo K, Sato K, Ono F et al. Biodistribution of a low dose of intravenously administered AAV-2, 10, and 11 vectors to cynomolgus monkeys. Jpn J Infect Dis 2006; 59: 285-293. (Pubitemid 44650371)
20. Favre D, Provost N, Blouin V, Blancho G, Chérel Y, Salvetti A et al. Immediate and long-term safety of recombinant adeno-associated virus injection into the nonhuman primate muscle. Mol Ther 2001; 4: 559-566. (Pubitemid 34026871)
21. Toromanoff A, Chérel Y, Guilbaud M, Penaud-Budloo M, Snyder RO, Haskins ME et al. Safety and efficacy of regional intravenous (r.i.) versus intramuscular (i.m.) delivery of rAAV1 and rAAV8 to nonhuman primate skeletal muscle. Mol Ther 2008; 16: 1291-1299. (Pubitemid 351866061)
22. Louboutin JP, Wang L, Wilson JM. Gene transfer into skeletal muscle using novel AAV serotypes. J Gene Med 2005; 7: 442-451. (Pubitemid 40553125)
23. Simon P. Q-Gene: processing quantitative real-time RT-PCR data. Bioinformatics 2003; 19: 1439-1440. (Pubitemid 36939825)
24. Simon P, Feldkaemper M, Bitzer M, Ohngemach S, Schaeffel F. Early transcriptional changes of retinal and choroidal TGFbeta-2, RALDH-2, and ZENK following imposed positive and negative defocus in chickens. Mol Vis 2004; 24: 588-597. (Pubitemid 41358238)